Global Dexcom Warriors Program Launches in Australia

SYDNEY, Australia – 1 March 2023: Dexcom Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring for people with diabetes, and its Australian subsidiary Australasian Medical and Scientific Ltd (AMSL Diabetes) today announce the official launch of the Dexcom Warrior program in Australia.

The Dexcom Warrior Program is a global advocacy community that aims to raise local awareness and understanding about living with diabetes. With support from locally based diabetes advocates, the program works to improve the availability of diabetes support, education and access to continuous glucose monitoring (CGM) technology for everyone with type 1 diabetes.

The Dexcom Warriors global community involves more than 20,000 members including celebrities, influencers and people in their own local communities who are all doing great work to raise awareness about the reality of living with diabetes.

Gillian Hebden from AMSL Diabetes said, “The Dexcom Warrior program has amassed a large global following of people who are passionate about living – and thriving – with diabetes. It provides exciting opportunities for local Dexcom CGM users to join this powerful global community and participate in the #WARRIORUP conversation, encouraging people to share their stories to empower, inform and inspire each other in their diabetes journey.”

The Dexcom Warrior program is open to Dexcom CGM users. We invite our Aussie Dexcom users to sign up at dexcom.com/en-au/dexcom-warriors

About DexCom, Inc.

DexCom, Inc. empowers people to take real-time control of diabetes through innovative continuous glucose monitoring (CGM) systems. Headquartered in San Diego, California, and with operations across Europe and select parts of Asia/Oceania, Dexcom has emerged as a leader in diabetes care technology. By listening to the needs of users, caregivers, and providers, Dexcom simplifies and improves diabetes management around the world. For more information about Dexcom CGM, visit dexcom.com/en-AU.

About AMSL

AMSL and its parent company, NZMS in New Zealand, are subsidiaries of Dexcom. They supply medical and scientific technologies to Australia and New Zealand. They form partnerships with world leading medical device, pharmaceutical and scientific innovators to introduce and establish advances in healthcare and science for the benefit of patients, healthcare providers and quality assurance professionals.

ALWAYS READ THE LABEL AND FOLLOW THE DIRECTIONS FOR USE. Read the warnings available on http://amsldiabete.wpenginepowered.com/resources before purchasing. Consult your healthcare professional to see if this product is right for you.